Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06605001 · ClinicalTrials.gov registry record · NA
Development, Attention, and Inhibition Study
A NA study of Delaying, sponsored by University of California, Davis.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT06605001: Recruiting NA study of Delaying, sponsored by University of California, Davis.
NCT06605001 is a NA study of Delaying that is actively recruiting participants, run by University of California, Davis. The registered enrollment target is 200 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06605001, a NA study of Delaying, is actively recruiting participants, sponsored by University of California, Davis.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to test the associations of young children's early life experiences with delaying behaviors and links with later life outcomes. The main questions it aims to answer are: * Do experiences with waiting in early childhood predict delaying behavior in context-specific ways? * Are links between delaying behavior and life outcomes impacted by social conventions, effort and choices around delaying, or other behaviors? Participants will: * Complete two delaying tasks with either a sweet or wrapped gift * Complete three "Simon says"-like games that measure inhibition, cognitive flexibility and proactive control * Answer a set of questions about academic readiness * Answer a set of questions about social conventions * Complete a waiting game on the computer while a camera records eye movements * Parents will answer questions about their child's behaviors and experiences at home * Participants will return after 1 year to repeat a subset of these measures
Primary Outcome
Pattern of waiting behavior represented by area under the curve (AUC) for wait times.
Conditions Studied
Interventions
- OTHER Delay of Gratification
Study Locations (1)
California
- Center for Mind and Brain - Davis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2024-08-21 |
| Est. Completion | 2026-03-01 |
| Phase | NA |
What NCT06605001 shows while recruiting
NCT06605001 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).
The record links to 1 condition, with Delaying appearing as the primary indexed condition, and to 1 intervention - of which Delay of Gratification is the first listed.
NCT06605001 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06605001 about?
NCT06605001 is a clinical study titled "Development, Attention, and Inhibition Study". The goal of this clinical trial is to test the associations of young children's early life experiences with delaying behaviors and links with later life outcomes. The main questions it aims to answer are: * Do experiences with waiting in early childhood predict delaying behavior in context-specific...
What is the current status of trial NCT06605001?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2024-08-21. Estimated completion is 2026-03-01.
What conditions does trial NCT06605001 study?
This clinical trial studies the following conditions: Delaying.
What interventions are being tested in trial NCT06605001?
The interventions under investigation include: Delay of Gratification (OTHER).
Who is sponsoring clinical trial NCT06605001?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06605001 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06605001's enrollment target sits among peer trials
200 506th of 2000 higher than 1,434 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI